| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.098 | 0.06 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.06 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.096 | 0.06 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.082 | 0.07 |